Initiation of single- and multiple-inhaler triple therapy for COPD and adoption of  budesonide/glycopyrrolate/formoterol (BGF): pooled analysis from the AURA Germany study, European Respiratory Society (ERS) congress.

Startseite » Publikationen » Initiation of single- and multiple-inhaler triple therapy for COPD and adoption of  budesonide/glycopyrrolate/formoterol (BGF): pooled analysis from the AURA Germany study, European Respiratory Society (ERS) congress.